Cite
APA Citation
Michaelsen, S. R., Staberg, M., Pedersen, H., Jensen, K. E., Majewski, W., Broholm, H., Nedergaard, M. K., Meulengracht, C., Urup, T., Villingshøj, M., Lukacova, S., Skjøth-Rasmussen, J., Brennum, J., Kjær, A., Lassen, U., Stockhausen, M., Poulsen, H. S., & Hamerlik, P. (2018). vEGF-C sustains VEGFR2 activation under bevacizumab therapy and promotes glioblastoma maintenance. Neuro-oncology, 20(11), 1462–1474. http://access.bl.uk/ark:/81055/vdc_100095498430.0x000014